Page Loader Image
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
Public Pharma For Europe
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact

Per un’agenzia pubblica europea per la ricerca e la produzione di farmaci

Read More »

Public Pharma for Europe: The case of CAR-T cell therapy

Read More »

Improving public access to medicines and promoting pharmaceutical innovation

Read More »

European pharmaceutical research and development: Could public infrastructure overcome market failures?

Read More »

Transformative policies to realise universal access to medicines: Why we need knowledge commons and public options for pharmaceuticals to realise the right to health

Read More »

A European Salk Institute Could Ensure Accessible and Affordable Medicines

Read More »

Medicine For All: The Case for a Public Option in the Pharmaceutical Industry

Read More »

PBM, Procurement, and production: Public Pharma strategies for state to lower insulin prices

Read More »

What is a Public-Commons Partnership?

Read More »

Lenacapavir: quanto custa defender a saúde pública?

Read More »
Page1 Page2 Page3 Page4

Keep In Touch

Twitter Instagram Mastodon Linkedin

MENU

  • About us
  • Events
  • Knowledge Hub
  • Resources
  • Contact